BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 16979425)

  • 1. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
    Knudsen S; Gammeltoft S; Jennum PJ
    Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
    Sturzenegger C; Bassetti CL
    J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between CSF hypocretin levels and hypocretin neuronal loss.
    Gerashchenko D; Murillo-Rodriguez E; Lin L; Xu M; Hallett L; Nishino S; Mignot E; Shiromani PJ
    Exp Neurol; 2003 Dec; 184(2):1010-6. PubMed ID: 14769395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Narcolepsy in Parkinson's disease.
    Haq IZ; Naidu Y; Reddy P; Chaudhuri KR
    Expert Rev Neurother; 2010 Jun; 10(6):879-84. PubMed ID: 20518604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics and treatment of narcolepsy.
    Dauvilliers Y; Tafti M
    Ann Med; 2006; 38(4):252-62. PubMed ID: 16754256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of sleep-wake patterns in a novel transgenic mouse line overexpressing human prepro-orexin/hypocretin.
    Mäkelä KA; Wigren HK; Zant JC; Sakurai T; Alhonen L; Kostin A; Porkka-Heiskanen T; Herzig KH
    Acta Physiol (Oxf); 2010 Mar; 198(3):237-49. PubMed ID: 20003098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypocretin/orexin, sleep and narcolepsy.
    Hungs M; Mignot E
    Bioessays; 2001 May; 23(5):397-408. PubMed ID: 11340621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
    Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
    J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Narcolepsy--new implications of molecular biology].
    Knudsen S; Jennum PJ
    Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nacrolepsy manifesting initially as cataplexy and sleep paralysis: usefulness of CSF hypocretin-1 examination for early diagnosis].
    Kobayashi Y; Miyamoto M; Miyamoto T; Yamazaki K; Hirata K; Kanbayashi T; Shimizu T
    Rinsho Shinkeigaku; 2002 Mar; 42(3):233-6. PubMed ID: 12474294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypocretin (orexin) deficiency in narcolepsy-cataplexy].
    Nevsímalová S; Vanková J; Sonka K; Faraco J; Rogers W; Overeem S; Mignot E
    Sb Lek; 2000; 101(4):381-6. PubMed ID: 11702580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
    Baumann CR; Bassetti CL
    Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Narcolepsy: new understanding of irresistible sleep.
    Krahn LE; Black JL; Silber MH
    Mayo Clin Proc; 2001 Feb; 76(2):185-94. PubMed ID: 11213307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.